HP and acute kidney injury: Given the detrimental effects of both free hemoglobin and its degradation products (including heme and NTBI) on the kidney, one potential therapeutic strategy for treating hemolysis-induced or iron-mediated AKI is the administration of haptoglobin to enhance the scavenging of free hemoglobin [46].